Stodden G R, Lindberg M E, King M L, Paquet M, MacLean J A, Mann J L, DeMayo F J, Lydon J P, Hayashi K
Department of Physiology, Southern Illinois University School of Medicine, Carbondale, IL, USA.
Departement de Pathologie et de Microbiologie, Université de Montreal, St-Hyacinthe, Quebec, Canada.
Oncogene. 2015 May 7;34(19):2471-82. doi: 10.1038/onc.2014.193. Epub 2014 Jul 7.
Type II endometrial carcinomas (ECs) are estrogen independent, poorly differentiated tumors that behave in an aggressive manner. As TP53 mutation and CDH1 inactivation occur in 80% of human endometrial type II carcinomas, we hypothesized that mouse uteri lacking both Trp53 and Cdh1 would exhibit a phenotype indicative of neoplastic transformation. Mice with conditional ablation of Cdh1 and Trp53 (Cdh1(d/d)Trp53(d/d)) clearly demonstrate architectural features characteristic of type II ECs, including focal areas of papillary differentiation, protruding cytoplasm into the lumen (hobnailing) and severe nuclear atypia at 6 months of age. Further, Cdh1(d/d)Trp53(d/d) tumors in 12-month-old mice were highly aggressive, and metastasized to nearby and distant organs within the peritoneal cavity, such as abdominal lymph nodes, mesentery and peri-intestinal adipose tissues, demonstrating that tumorigenesis in this model proceeds through the universally recognized morphological intermediates associated with type II endometrial neoplasia. We also observed abundant cell proliferation and complex angiogenesis in the uteri of Cdh1(d/d)Trp53(d/d) mice. Our microarray analysis found that most of the genes differentially regulated in the uteri of Cdh1(d/d)Trp53(d/d) mice were involved in inflammatory responses. CD163 and Arg1, markers for tumor-associated macrophages, were also detected and increased in the uteri of Cdh1(d/d)Trp53(d/d) mice, suggesting that an inflammatory tumor microenvironment with immune cell recruitment is augmenting tumor development in Cdh1(d/d)Trp53(d/d) uteri. Further, inflammatory mediators secreted from CDH1-negative, TP53 mutant endometrial cancer cells induced normal macrophages to express inflammatory-related genes through activation of nuclear factor-κB signaling. These results indicate that absence of CDH1 and TP53 in endometrial cells initiates chronic inflammation, promotes tumor microenvironment development following the recruitment of macrophages and promotes aggressive ECs.
II型子宫内膜癌(ECs)是雌激素非依赖性、低分化肿瘤,具有侵袭性。由于80%的人类II型子宫内膜癌发生TP53突变和CDH1失活,我们推测同时缺失Trp53和Cdh1的小鼠子宫会表现出肿瘤转化的表型。条件性敲除Cdh1和Trp53的小鼠(Cdh1(d/d)Trp53(d/d))在6月龄时明显表现出II型ECs的结构特征,包括乳头样分化的局灶区域、细胞质突入管腔(鞋钉样)和严重的核异型性。此外,12月龄Cdh1(d/d)Trp53(d/d)小鼠的肿瘤具有高度侵袭性,并转移至腹腔内的附近和远处器官,如腹部淋巴结、肠系膜和肠周脂肪组织,表明该模型中的肿瘤发生通过与II型子宫内膜肿瘤形成相关的普遍公认的形态学中间阶段进行。我们还观察到Cdh1(d/d)Trp53(d/d)小鼠子宫中有丰富的细胞增殖和复杂的血管生成。我们的微阵列分析发现,Cdh1(d/d)Trp53(d/d)小鼠子宫中差异调节的大多数基因参与炎症反应。肿瘤相关巨噬细胞的标志物CD163和Arg1在Cdh1(d/d)Trp53(d/d)小鼠子宫中也被检测到且表达增加,这表明具有免疫细胞募集的炎症性肿瘤微环境正在促进Cdh1(d/d)Trp53(d/d)小鼠子宫中的肿瘤发展。此外,CDH1阴性、TP53突变的子宫内膜癌细胞分泌的炎症介质通过激活核因子κB信号诱导正常巨噬细胞表达炎症相关基因。这些结果表明,子宫内膜细胞中CDH1和TP53的缺失引发慢性炎症,在巨噬细胞募集后促进肿瘤微环境的发展,并促进侵袭性ECs的发生。